Young RP, Hopkins RJ, Christmas T, Black PN, Metcalf P, Gamble GD. COPD prevalence is increased in lung cancer, independent of age, sex and smoking history. Eur Respir J. 2009;34:380–6.

Article  CAS  PubMed  Google Scholar 

Young RP, Duan F, Chiles C, Hopkins RJ, Gamble GD, Greco EM, Gatsonis C, Aberle D. Airflow Limitation and Histology Shift in the National Lung Screening Trial. The NLST-ACRIN cohort Substudy. Am J Respir Crit Care Med. 2015;192:1060–7.

Article  PubMed  PubMed Central  Google Scholar 

Wasswa-Kintu S, Gan WQ, Man SF, Pare PD, Sin DD. Relationship between reduced forced expiratory volume in one second and the risk of lung cancer: a systematic review and meta-analysis. Thorax. 2005;60:570–5.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wilson DO, Weissfeld JL, Balkan A, Schragin JG, Fuhrman CR, Fisher SN, Wilson J, Leader JK, Siegfried JM, Shapiro SD, Sciurba FC. Association of radiographic emphysema and airflow obstruction with lung cancer. Am J Respir Crit Care Med. 2008;178:738–44.

Article  PubMed  PubMed Central  Google Scholar 

Mannino DM, Aguayo SM, Petty TL, Redd SC. Low lung function and incident lung cancer in the United States: data from the First National Health and Nutrition Examination Survey follow-up. Arch Intern Med. 2003;163:1475–80.

Article  PubMed  Google Scholar 

Ahn SV, Lee E, Park B, Jung JH, Park JE, Sheen SS, Park KJ, Hwang SC, Park JB, Park HS, Park JH. Cancer development in patients with COPD: a retrospective analysis of the National Health Insurance Service-National Sample Cohort in Korea. BMC Pulm Med. 2020;20:170.

Article  PubMed  PubMed Central  Google Scholar 

Barnes PJ, Adcock IM. Chronic obstructive pulmonary disease and lung cancer: a lethal association. Am J Respir Crit Care Med. 2011;184:866–7.

Article  PubMed  Google Scholar 

Adcock IM, Caramori G, Barnes PJ. Chronic obstructive pulmonary disease and lung cancer: new molecular insights. Respiration. 2011;81:265–84.

Article  CAS  PubMed  Google Scholar 

Park HY, Kang D, Shin SH, Choi H, Jang SH, Lee CH, Kim H, Kwon OJ, Rhee CK, Cho J. Pulmonary tuberculosis and the incidence of Lung Cancer among patients with chronic obstructive Pulmonary Disease. Ann Am Thorac Soc. 2022;19:640–8.

Article  PubMed  Google Scholar 

King PT. Inflammation in chronic obstructive pulmonary disease and its role in cardiovascular disease and lung cancer. Clin Transl Med. 2015;4:68.

Article  PubMed  Google Scholar 

Lee G, Walser TC, Dubinett SM. Chronic inflammation, chronic obstructive pulmonary disease, and lung cancer. Curr Opin Pulm Med. 2009;15:303–7.

Article  CAS  PubMed  Google Scholar 

Lee YM, Kim SJ, Lee JH, Ha E. Inhaled corticosteroids in COPD and the risk of lung cancer. Int J Cancer. 2018;143:2311–8.

Article  CAS  PubMed  Google Scholar 

Pitre T, Kiflen M, Ho T, Seijo LM, Zeraatkar D, de Torres JP. Inhaled corticosteroids, COPD, and the incidence of lung cancer: a systematic review and dose response meta-analysis. BMC Pulm Med. 2022;22:275.

Article  PubMed  PubMed Central  Google Scholar 

Suissa S, Dell’Aniello S, Gonzalez AV, Ernst P. Inhaled corticosteroid use and the incidence of lung cancer in COPD. Eur Respir J. 2020;55:1901720.

Raymakers AJN, Sadatsafavi M, Sin DD, FitzGerald JM, Marra CA, Lynd LD. Inhaled corticosteroids and the risk of lung cancer in COPD: a population-based cohort study. Eur Respir J. 2019;53:1801257.

Parimon T, Chien JW, Bryson CL, McDonell MB, Udris EM, Au DH. Inhaled corticosteroids and risk of lung cancer among patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2007;175:712–9.

Article  CAS  PubMed  Google Scholar 

Liu SF, Kuo HC, Lin MC, Ho SC, Tu ML, Chen YM, Chen YC, Fang WF, Wang CC, Liu GH. Inhaled corticosteroids have a protective effect against lung cancer in female patients with chronic obstructive pulmonary disease: a nationwide population-based cohort study. Oncotarget. 2017;8:29711–21.

Article  PubMed  PubMed Central  Google Scholar 

Kiri VA, Fabbri LM, Davis KJ, Soriano JB. Inhaled corticosteroids and risk of lung cancer among COPD patients who quit smoking. Respir Med. 2009;103:85–90.

Article  PubMed  Google Scholar 

Lee CH, Hyun MK, Jang EJ, Lee NR, Kim K, Yim JJ. Inhaled corticosteroid use and risks of lung cancer and laryngeal cancer. Respir Med. 2013;107:1222–33.

Article  PubMed  Google Scholar 

Barnes PJ. Inhaled corticosteroids. Pharmaceuticals (Basel). 2010;3:514–40.

Article  CAS  PubMed  Google Scholar 

Jian ZH, Huang JY, Lin FC, Nfor ON, Jhang KM, Ku WY, Ho CC, Lung CC, Pan HH, Liang YC, et al. The use of corticosteroids in patients with COPD or asthma does not decrease lung squamous cell carcinoma. BMC Pulm Med. 2015;15:154.

Article  PubMed  PubMed Central  Google Scholar 

Kok VC, Horng JT, Huang HK, Chao TM, Hong YF. Regular inhaled corticosteroids in adult-onset asthma and the risk for future cancer: a population-based cohort study with proper person-time analysis. Ther Clin Risk Manag. 2015;11:489–99.

Article  PubMed  PubMed Central  Google Scholar 

Sørli K, Thorvaldsen SM, Hatlen P. Use of Inhaled corticosteroids and the risk of Lung Cancer, the HUNT study. Lung. 2018;196:179–84.

Article  PubMed  Google Scholar 

Suissa S. Immortal time bias in observational studies of drug effects. Pharmacoepidemiol Drug Saf. 2007;16:241–9.

Article  PubMed  Google Scholar 

Rivera DR, McGlynn KA, Freedman AN. Connections between pharmacoepidemiology and cancer biology: designing biologically relevant studies of cancer outcomes. Ann Epidemiol. 2016;26:741–5.

Article  PubMed  PubMed Central  Google Scholar 

Horwitz RI, Feinstein AR. The problem of protopathic bias in case-control studies. Am J Med. 1980;68:255–8.

Article  CAS  PubMed  Google Scholar 

Yang CC, Fong Y, Lin LC, Que J, Ting WC, Chang CL, Wu HM, Ho CH, Wang JJ, Huang CI. The age-adjusted Charlson comorbidity index is a better predictor of survival in operated lung cancer patients than the Charlson and Elixhauser comorbidity indices. Eur J Cardiothorac Surg. 2018;53:235–40.

Article  PubMed  Google Scholar 

Marcus MW, Chen Y, Duffy SW, Field JK. Impact of comorbidity on lung cancer mortality - a report from the Liverpool Lung Project. Oncol Lett. 2015;9:1902–6.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Maldonado F, Bartholmai BJ, Swensen SJ, Midthun DE, Decker PA, Jett JR. Are airflow obstruction and radiographic evidence of emphysema risk factors for lung cancer? A nested case-control study using quantitative emphysema analysis. Chest. 2010;138:1295–302.

Article  PubMed  Google Scholar 

Turner MC, Chen Y, Krewski D, Calle EE, Thun MJ. Chronic obstructive pulmonary disease is associated with lung cancer mortality in a prospective study of never smokers. Am J Respir Crit Care Med. 2007;176:285–90.

Article  PubMed  Google Scholar 

Vestbo J, Edwards LD, Scanlon PD, Yates JC, Agusti A, Bakke P, Calverley PM, Celli B, Coxson HO, Crim C, et al. Changes in forced expiratory volume in 1 second over time in COPD. N Engl J Med. 2011;365:1184–92.

Article  CAS  PubMed  Google Scholar 

Brown SW, Dobelle M, Padilla M, Agovino M, Wisnivesky JP, Hashim D, Boffetta P. Idiopathic pulmonary fibrosis and Lung Cancer. A systematic review and Meta-analysis. Ann Am Thorac Soc. 2019;16:1041–51.

Article  PubMed  Google Scholar 

Kitaguchi Y, Fujimoto K, Hanaoka M, Kawakami S, Honda T, Kubo K. Clinical characteristics of combined pulmonary fibrosis and emphysema. Respirology. 2010;15:265–71.

Article  PubMed  Google Scholar 

Mizuno S, Takiguchi Y, Fujikawa A, Motoori K, Tada Y, Kurosu K, Sekine Y, Yanagawa N, Hiroshima K, Muraoka K, et al. Chronic obstructive pulmonary disease and interstitial lung disease in patients with lung cancer. Respirology. 2009;14:377–83.

Article  PubMed  Google Scholar 

Kinoshita T, Goto T. Molecular mechanisms of Pulmonary Fibrogenesis and its progression to Lung Cancer: a review. Int J Mol Sci. 2019;20:1461.

Tzouvelekis A, Gomatou G, Bouros E, Trigidou R, Tzilas V, Bouros D. Common pathogenic mechanisms between idiopathic pulmonary fibrosis and Lung Cancer. Chest. 2019;156:383–91.

Article  PubMed  Google Scholar